These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7554285)

  • 1. The typing of fetal antigen 2 in human amniotic fluid.
    Price KM; Silman R; Armstrong P; Teisner B; Grudzinskas JG
    Clin Chim Acta; 1995 May; 236(2):181-94. PubMed ID: 7554285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the aminopropeptide of procollagen (alpha 1) I in human amniotic fluid.
    Price KM; Silman R; Grudzinskas JG
    Biochem Soc Trans; 1994 May; 22(2):218S. PubMed ID: 7958280
    [No Abstract]   [Full Text] [Related]  

  • 3. Fetal antigen 2: an amniotic protein identified as the aminopropeptide of the alpha 1 chain of human procollagen type I.
    Teisner B; Rasmussen HB; Højrup P; Yde-Andersen E; Skjødt K
    APMIS; 1992 Dec; 100(12):1106-14. PubMed ID: 1492979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal amniotic fetal antigen 2 concentrations in trisomy 18 and trisomy 21.
    Price KM; Silman R; Armstrong P; Grudzinskas JG
    Hum Reprod; 1995 Sep; 10(9):2438-40. PubMed ID: 8530681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal antigen 2 (FA2): the aminopropeptide of the alpha 1 chain of human type I procollagen. A study on skin, tumour biology and bone metabolism.
    Rasmussen HB
    APMIS Suppl; 1993; 39():1-28. PubMed ID: 8297640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the N-terminal propeptide of human procollagen type I (PINP): comparison of ELISA and RIA with respect to different molecular forms.
    Jensen CH; Hansen M; Brandt J; Rasmussen HB; Jensen PB; Teisner B
    Clin Chim Acta; 1998 Jan; 269(1):31-41. PubMed ID: 9498102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of fetal antigen 2 and assay standardisation.
    Price KM; Silman R; Grudzinskas JG
    Clin Chim Acta; 1994 Apr; 226(1):83-8. PubMed ID: 8070136
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a radioimmunoassay for fetal antigen 2.
    Price KM; Silman R; Armstrong P; Grudzinskas JG
    Clin Chim Acta; 1994 Jan; 224(1):95-102. PubMed ID: 8174284
    [No Abstract]   [Full Text] [Related]  

  • 9. Thermal instability of the trimeric structure of the N-terminal propeptide of human procollagen type I in relation to assay technology.
    Brandt J; Krogh TN; Jensen CH; Frederiksen JK; Teisner B
    Clin Chem; 1999 Jan; 45(1):47-53. PubMed ID: 9895337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of non-maternal serum proteins in amniotic fluid at weeks 16 to 18 of gestation.
    Drøhse H; Christensen H; Myrhøj V; Sørensen S
    Clin Chim Acta; 1998 Aug; 276(2):109-20. PubMed ID: 9764729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen synthesis by human amniotic fluid cells in culture: characterization of a procollagen with three identical proalpha1(I) chains.
    Crouch E; Bornstein P
    Biochemistry; 1978 Dec; 17(25):5499-509. PubMed ID: 215203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of the N-terminal propeptide of human type III procollagen.
    Niemelä O; Risteli L; Parkkinen J; Risteli J
    Biochem J; 1985 Nov; 232(1):145-50. PubMed ID: 4084223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagenous constituents of amniotic fluid.
    Gogiel T; Bielecki DA; Bańkowski E
    Acta Biochim Pol; 1998; 45(4):1037-46. PubMed ID: 10397350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
    Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
    Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isolation of activin from ovine amniotic fluid.
    de Kretser DM; Foulds LM; Hancock M; McFarlane J; Goss N; Jenkin G
    Endocrinology; 1994 Mar; 134(3):1231-7. PubMed ID: 8119164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bony metastases from breast cancer - a study of foetal antigen 2 as a blood tumour marker.
    Cheung KL; Iles RK; Robertson JF
    World J Surg Oncol; 2010 May; 8():38. PubMed ID: 20465790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunochemical identification of the fetal polypeptides of human amniotic fluid during the second trimester of pregnancy.
    Prado VF; Reis DD; Pena SD
    Braz J Med Biol Res; 1990; 23(2):121-31. PubMed ID: 2207440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-based approach for identification and purification of human phosphate binding apolipoprotein from amniotic fluid.
    Alam M; Mahajan M; Raziuddin M; Singh TP; Yadav S
    Genet Mol Res; 2009 Aug; 8(3):929-37. PubMed ID: 19731215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of endometrial protein PP14 from mid-trimester amniotic fluid.
    Riittinen L; Julkunen M; Seppälä M; Koistinen R; Huhtala ML
    Clin Chim Acta; 1989 Sep; 184(1):19-29. PubMed ID: 2688994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of high-risk pregnancies: a biochemical approach to the dynamic assessment of deviant fetal growth.
    Vanhaesebrouck P; Kint J; Van Kets H; Govaert P; Smets K; Defoort P; Leroy J
    Pediatr Res; 1994 Jul; 36(1 Pt 1):71-6. PubMed ID: 7936841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.